Literature DB >> 4544224

Myasthenia gravis, autoantibodies, and HL-A antigens.

T E Feltkamp, P M van den Berg-Loonen, L E Nijenhuis, C P Engelfriet, A L van Rossum, J J van Loghem, H J Oosterhuis.   

Abstract

The serum of 100 patients with myasthenia gravis and 441 of their first-degree relatives was studied for the presence of autoantibodies against several antigens. Antibodies to skeletal muscle were present in 22% of the patients and in 2% of the relatives. Both these frequencies were significantly higher than those in matched control subjects. Also, antinuclear antibodies were present more often both in the patients and in the relatives. Typing for HL-A antigens had shown a positive correlation between HL-A 8 and myasthenia gravis which was significantly higher in women than in men. Antibodies to skeletal muscle and thymomas were found to be much rarer in HL-A 8-positive patients than in HL-A 8-negative patients; HL-A 8-positive patients acquired the disease at an earlier age.HL-A 2-positive patients more often had thymomas and antibodies to skeletal muscle than HL-A 2-negative patients; HL-A 2-positive patients acquired myasthenia gravis at a later age.The fact that the clinical aspects of the HL-A 8-negative and HL-A 2-positive patients were different from those of the HL-A 8-positive and HL-A 2-negative patients justifies the hypothesis that there are two forms of myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4544224      PMCID: PMC1633001          DOI: 10.1136/bmj.1.5899.131

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  AN EVALUATION OF GASTRIC AND THYROID AUTO-IMMUNITY IN RELATION TO HEMATOLOGIC DISORDERS.

Authors:  D DONIACH; I M ROITT
Journal:  Semin Hematol       Date:  1964-07       Impact factor: 3.851

2.  The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration.

Authors:  I AIRD; H H BENTALL; J A MEHIGAN; J A F ROBERTS
Journal:  Br Med J       Date:  1954-08-07

Review 3.  Protein clinical manifestations of primary tumors of the heart.

Authors:  H O McDevitt; W F Bodmer
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

4.  Measles antibodies in sera from patients with autoimmune diseases.

Authors:  C J Lucas; R Brouwer; T E Feltkamp; J H ten Veen; J J van Loghem
Journal:  Lancet       Date:  1972-01-15       Impact factor: 79.321

5.  Scandiatransplant: preliminary report of a kidney exchange program.

Authors:  F Kissmeyer-Nielsen; A Svejgaard; O Fjeldborg; V P Petersen; L Staub Nielsen; F Lund; E Clausen; J Hess Thaysen; E Kemp; H Rahbeck Sorensen; E Thorsby; E Brodwall; A Flatmark; F Bergan; E Enger; O J Malm; L Sandberg; A Lindholm; L E Gelin; C Högman; K E Fjellström; L Thoren; E Möller
Journal:  Transplant Proc       Date:  1971-06       Impact factor: 1.066

6.  Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report.

Authors:  R Pirskanen; A Tiilikainen; E Hokkanen
Journal:  Ann Clin Res       Date:  1972-10

7.  Immunological studies in patients with juvenile-onset myasthenia gravis and in their relatives.

Authors:  S Bundey; D Doniach; J F Soothill
Journal:  Clin Exp Immunol       Date:  1972-07       Impact factor: 4.330

8.  Autoimmunity in myasthenia gravis: a family study.

Authors:  R Wright; J H Kerr
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

9.  The familial occurrence of myasthenia gravis.

Authors:  C Herrmann
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

  9 in total
  30 in total

Review 1.  Diseases associated with specific HL-A antigens.

Authors:  J H Oh; L D MacLean
Journal:  Can Med Assoc J       Date:  1975-06-07       Impact factor: 8.262

2.  Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAg.

Authors:  D P Sengar; W A McLeish; M Sutherland; R A Couture; A Rashid
Journal:  Can Med Assoc J       Date:  1975-04-19       Impact factor: 8.262

3.  Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

Authors:  R C Bucknall
Journal:  Proc R Soc Med       Date:  1977

4.  Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.

Authors:  Y Fujii; M Hayakawa; K Nakahara
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

5.  Genetic associations between myasthenia gravis and the HL-A system.

Authors:  R Pirskanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

6.  Genetic considerations on association between HLA and disease.

Authors:  L E Nijenhuis
Journal:  Hum Genet       Date:  1977-09-22       Impact factor: 4.132

7.  Lymphocyte subpopulations and surface membrane immunoglobulins in myasthenia gravis.

Authors:  G Landi; M Galli; G Ciboddo; G Colombo; G Scarlato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

8.  Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.

Authors:  A Vincent; H A Solleveld
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

Review 9.  Thymectomy in myasthenia gravis. A review.

Authors:  H J Oosterhuis
Journal:  Ital J Neurol Sci       Date:  1983-12

Review 10.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.